Chemoinformaics analysis of Diosgenone,4-dimethyl-
| Molecular Weight | 454.651 | nRot | 0 |
| Heavy Atom Molecular Weight | 412.315 | nRig | 32 |
| Exact Molecular Weight | 454.308 | nRing | 6 |
| Solubility: LogS | -6.018 | nHRing | 2 |
| Solubility: LogP | 5.634 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 79.6433 |
| nHD | 1 | BPOL | 46.4747 |
| QED | 0.346 |
| Synth | 5.508 |
| Natural Product Likeliness | 2.837 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.99 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.942 |
| MDCK | 0.0000288 |
| BBB | 0.404 |
| PPB | 0.971856 |
| VDSS | 1.089 |
| FU | 0.0219056 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.712 |
| CYP2c19-inh | 0.257 |
| CYP2c19-sub | 0.945 |
| CYP2c9-inh | 0.228 |
| CYP2c9-sub | 0.089 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.298 |
| CYP3a4-inh | 0.724 |
| CYP3a4-sub | 0.605 |
| CL | 14.027 |
| T12 | 0.014 |
| hERG | 0.005 |
| Ames | 0.061 |
| ROA | 0.424 |
| SkinSen | 0.049 |
| Carcinogencity | 0.177 |
| EI | 0.013 |
| Respiratory | 0.898 |
| NR-Aromatase | 0.799 |
| Antiviral | Yes |
| Prediction | 0.749926 |